DANIELLE BASSIL: Open Payments
NPI 1336977214 · HYANNIS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,435 in 47 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $148 · 2025 $1,435
Food & beverage: $1,435
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $237 |
| Vanda Pharmaceuticals Inc. | 5 | $227 |
| Alkermes, Inc. | 3 | $149 |
| Axsome Therapeutics, Inc. | 2 | $145 |
| Otsuka America Pharmaceutical, Inc. | 9 | $143 |
| Biogen, Inc. | 1 | $116 |
| ABBVIE INC. | 4 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $97 |
| Janssen Pharmaceuticals, Inc | 2 | $73 |
| Neurocrine BioSciences, Inc. | 2 | $59 |
Products named: COBENFY, FANAPT, Auvelity, REXULTI, ZURZUVAE, LYBALVI, VRAYLAR, CAPLYTA.
Industry payments across MA — which companies pay providers there.
